A novel SARS-CoV-2 Beta RBD DNA vaccine directly targeted to antigen-presenting cells induces strong humoral and T cell responses.
Kuczkowska K, Bjerkan L, Stubsrud E, Husbyn HC, Chellappa S, Hauge A, Skarshaug R, Torgersen ML, Heim JB, Jørgensen MJ, Wold CW, Schleimann MH, Tolstrup M, Granum S, Fredriksen AB, Pedersen MW, Norheim G.
Kuczkowska K, et al. Among authors: wold cw.
Sci Rep. 2023 Nov 2;13(1):18902. doi: 10.1038/s41598-023-46223-8.
Sci Rep. 2023.
PMID: 37919366
Free PMC article.